MedTrace Logo

Intra Versus Extra-thoracic Oscillations in Chronic Obstructive Pulmonary Disease

NCT03885128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-08-30

No results posted yet for this study

Summary

Chronic Obstructive Pulmonary Disease (COPD) is the fourth-leading cause of death. It is a progressive illness that requires life-long treatment.Promoting airway clearance (AC) using mucolytics together with airway clearance techniques (ACTs) form the basis for pulmonary therapy in COPD care.Therefore, new airway clearance modalities are required to decrease the detrimental effects of accumulated secretions in COPD.

One of the devices used in AC is the high frequency chest wall oscillation (The Vest). HFCWO involves the use of an inflatable vest/jacket that covers the chest and is attached to an air pulse-generating compressor which rapidly inflates and deflates the vest, producing oscillations to the chest wall of 5-25 Hz.

Another new airway clearance modality is oscillating positive expiratory pressure(Quake) which combines PEP therapy with high frequency oscillations.

Conditions

Interventions

DEVICE

High frequency extra thoracic oscillations vest

Oscillations applied extra thoracic through vest device aiming for airway clearance

DEVICE

Intrathoracic oscillatory quake

Oscillation introduced intrathoracic through quake device through placing quake in mouth and ordering patient to breathing to move secretions

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nagwa M Badr, Professor · Professor physical therapy at Cairo university

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
72 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-01
Primary Completion
2019-05-01
Completion
2019-05-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03885128 on ClinicalTrials.gov